These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 11911338)

  • 1. Hepatitis C virus (HCV) RNA level determined by second-generation branched-DNA probe assay as predictor of response to interferon treatment in patients with chronic HCV viremia.
    Furusyo N; Hayashi J; Kashiwagi K; Nakashima H; Nabeshima S; Sawayama Y; Kinukawa N; Kashiwagi S
    Dig Dis Sci; 2002 Mar; 47(3):535-42. PubMed ID: 11911338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of different hepatitis C serological assays in the treatment of chronic hepatitis C with interferon alpha.
    Kobayashi M; Chayama K; Arase Y; Tsubota A; Saitoh S; Suzuki Y; Kobayashi M; Kobayashi M; Ikeda K; Matsuda M; Koike H; Hashimoto M; Kumada H
    J Gastroenterol; 1999 Feb; 34(1):94-9. PubMed ID: 10204617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype, serum level of hepatitis C virus RNA and liver histology as predictors of response to interferon-alpha 2a therapy in Japanese patients with chronic hepatitis C.
    Mizokami M; Orito E; Gibo Y; Suzuki K; Ohba K; Ohno T; Lau JY
    Liver; 1996 Feb; 16(1):23-7. PubMed ID: 8868074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative viremia test for early prediction of a biochemical response in patients with chronic hepatitis C treated with interferon.
    Nardiello S; Gaeta GB; Pizzella T; Stornaiuolo G; Ascione T; Galanti B; Giusti G
    J Chemother; 2001 Aug; 13(4):424-8. PubMed ID: 11589486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of the total hepatitis C virus core antigen, branched-DNA, and amplicor monitor assays in determining viremia for patients with chronic hepatitis C during interferon plus ribavirin combination therapy.
    Veillon P; Payan C; Picchio G; Maniez-Montreuil M; Guntz P; Lunel F
    J Clin Microbiol; 2003 Jul; 41(7):3212-20. PubMed ID: 12843066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of simple assays for serum concentration of hepatitis C virus RNA and HCV genotype in predicting the response of patients with chronic hepatitis C to interferon alpha 2a therapy.
    Suzuki T; Tanaka E; Matsumoto A; Urushihara A; Sodeyama T
    J Med Virol; 1995 Jun; 46(2):162-8. PubMed ID: 7636506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of serum hepatitis C virus RNA concentration by branched DNA probe assay with competitive reverse transcription polymerase chain reaction as a predictor of response to interferon-alpha therapy in chronic hepatitis C patients.
    Toyoda H; Nakano S; Kumada T; Takeda I; Sugiyama K; Osada T; Kiriyama S; Orito E; Mizokami M
    J Med Virol; 1996 Apr; 48(4):354-9. PubMed ID: 8699168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response].
    Berg T; Kaul T; Naumann U; Wiedenmann B; Hopf U
    Z Gastroenterol; 2000 Nov; 38(11):881-6. PubMed ID: 11132533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of the efficacy of intravenous natural interferon-beta treatment in chronic hepatitis C.
    Fukutomi T; Fukutomi M; Iwao M; Watanabe H; Tanabe Y; Hiroshige K; Kinukawa N; Nakamuta M; Nawata H
    Med Sci Monit; 2000; 6(4):692-8. PubMed ID: 11208393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of hepatitis C virus RNA in serum by branched DNA-based signal amplification assays.
    Pawlotsky JM; Martinot-Peignoux M; Poveda JD; Bastie A; Le Breton V; Darthuy F; Rémiré J; Erlinger S; Dhumeaux D; Marcellin P
    J Virol Methods; 1999 May; 79(2):227-35. PubMed ID: 10381092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical performances of two real-time PCR assays and bDNA/TMA to early monitor treatment outcome in patients with chronic hepatitis C.
    Martinot-Peignoux M; Khiri H; Leclere L; Maylin S; Marcellin P; Halfon P
    J Clin Virol; 2009 Nov; 46(3):216-21. PubMed ID: 19748822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative measurement of serum HCV RNA in patients with chronic hepatitis C: comparison between Amplicor HCV monitor system and branched DNA signal amplification assay.
    Lu RH; Hwang SJ; Chan CY; Chang FY; Lee SD
    J Clin Lab Anal; 1998; 12(2):121-5. PubMed ID: 9524297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
    Nousbaum JB; Pol S; Nalpas B; Landais P; Berthelot P; Bréchot C
    Ann Intern Med; 1995 Feb; 122(3):161-8. PubMed ID: 7810932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial.
    Bresters D; Cuypers HT; Reesink HW; Mauser-Bunschoten EP; van den Berg HM; Schaasberg WP; Wilber JC; Urdea MS; Neuwald P; Lelie PN
    J Med Virol; 1994 Jul; 43(3):262-8. PubMed ID: 7931188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of reverse transcription-polymerase chain reaction and branched-chain DNA assays for hepatitis C virus RNA in patients receiving interferon treatment. Consensus Interferon Study Group.
    Pockros PJ; Bain VG; Hunter EB; Conrad A; Balart A; Hollinger FB; Albert D
    J Viral Hepat; 1999 Mar; 6(2):145-50. PubMed ID: 10607226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-alpha therapy in Japanese patients with chronic hepatitis C.
    Orito E; Mizokami M; Nakano T; Terashima H; Nojiri O; Sakakibara K; Mizuno M; Ogino M; Nakamura M; Matsumoto Y
    J Med Virol; 1994 Dec; 44(4):410-4. PubMed ID: 7897373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of HCV RNA levels by branched DNA probe assay and by competitive polymerase chain reaction to predict effectiveness of interferon treatment for patients with chronic hepatitis C virus.
    Hayashi J; Kawakami Y; Nabeshima A; Kishihara Y; Furusyo N; Sawayama Y; Kinukawa N; Kashiwagi S
    Dig Dis Sci; 1998 Feb; 43(2):384-91. PubMed ID: 9512135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of viral genotype and level of viremia on the severity of liver injury and the response to interferon therapy in Spanish patients with chronic C infection.
    Fernández I; Castellano G; Domingo MJ; Fuertes A; Colina F; Canga F; de la Cruz FJ; de la Cámara AG; Solís JA
    Scand J Gastroenterol; 1997 Jan; 32(1):70-6. PubMed ID: 9018770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral kinetics can predict early response to alpha-interferon in chronic hepatitis C.
    Walsh KM; Good T; Cameron S; Thorburn D; McCruden EA; Mills PR; Morris AJ
    Liver; 1998 Jun; 18(3):191-5. PubMed ID: 9716230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group.
    Saracco G; Ciancio A; Ghisetti V; Rocca G; Cariti G; Andreoni M; Tabone M; Roffi L; Calleri G; Ballaré M; Terreni N; Sartori M; Tappero GF; Traverso A; Poggio A; Orani A; Maggi G; Di Napoli A; Arrigoni A; Rizzetto M;
    Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):149-55. PubMed ID: 11246614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.